NCT07076134Not yet recruiting
Community-and Primary Care-based Intervention Linked With mObile Technology for HTN Control in Nepal
A Pilot Trial of a Community-and Primary Care-based Intervention Linked With mObile Technology for Hypertension Control in Nepal (CoPILOT Trial)
Source: ClinicalTrials.gov · Last updated 17 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The clinical trial aims to evaluate whether a community and primary care-based intervention linked with mobile technology (CoPILOT) is acceptable, effective, cost-effective, sustainable, and scalable in improving hypertension (HTN) control among individuals aged 30 to 70 in Nepal. The primary research questions include: Is the use of the application by Frontline Health Workers (FLHWs) and Female Community Health Volunteers (FCHVs) feasible and acceptable? Can FCHVs equipped with mHealth technology effectively increase the linkage of individuals with elevated blood pressure (BP) to health facilities? Does a mobile-based lifestyle intervention reduce or control BP? Can adherence to prescribed HTN treatments be improved among patients through this intervention?
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 520 (estimated)
- First submitted
- 19 Nov 2024
- Start date
- 15 Aug 2025
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- Duke Kunshan University
- Diseases
- High blood pressure
- NCT number
- NCT07076134
What you commit to
- Study type: Interventional
- Planned participants: 520
- From 15 Aug 2025 to the primary completion date, 31 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participants who are not able to respond during the data collection period.
- Participants who are out of municipality during the data collection period.
Who the study is looking for
- Hypertensive patient's should be in the range of 30 to 70 years old living in selected communities with HTN (systolic BP ≥ 130 mmHg or diastolic ≥ 85 mmHg or taking antihypertensive medication)
- They should have been diagnosed previously and under medication.
- They should agree to the informed consent
- FCHVs should be working for the selected communities and agree to the informed consent
- FLHWs should work for the health facilities in selected communities and agree to the informed consent.
Age in the registry: 30 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Namobuddha municipality Coordinator of this site? Confirm its status | Namobuddha | Nepal | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.